Simplex Trading
TTPH

Simplex Trading’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Simplex Trading’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-36
Closed -$96K – 8211
2019
Q1 		$96K Buy
36
+35
+3,500% +$891 ﹤0.01% 4372
2018
Q4 		$1K Sell
1
-38
-97% -$1.49K ﹤0.01% 6854
2018
Q3 		$215K Buy
39
+35
+875% +$2.23K ﹤0.01% 3567
2018
Q2 		$26K Buy
4
+1
+33% +$71 ﹤0.01% 5669
2018
Q1 		$3K Buy
+3
New +$263 ﹤0.01% 5134
2017
Q4 		– Sell
-59
Closed -$34K – 7051
2017
Q3 		$34K Buy
59
+29
+97% +$3.88K ﹤0.01% 2668
2017
Q2 		$44K Buy
30
+10
+50% +$1.54K ﹤0.01% 2522
2017
Q1 		$115K Buy
20
+11
+122% +$1.23K 0.01% 1633
2016
Q4 		$4K Buy
9
+3
+50% +$237 ﹤0.01% 4635
2016
Q3 		$5K Sell
6
-3
-33% -$240 ﹤0.01% 4362
2016
Q2 		$14K Sell
9
-20
-69% -$1.83K ﹤0.01% 3280
2016
Q1 		$50K Buy
29
+4
+16% +$400 ﹤0.01% 1963
2015
Q4 		$57K Sell
25
-21
-46% -$4.19K ﹤0.01% 1822
2015
Q3 		$32K Buy
46
+44
+2,200% +$32.3K ﹤0.01% 2349
2015
Q2 		$33K Buy
2
+1
+100% +$818 ﹤0.01% 2019
2015
Q1 		$16K Sell
1
-1
-50% -$751 ﹤0.01% 2526
2014
Q4 		$81K Buy
+2
New +$1.08K 0.01% 1055

Other funds holding TTPH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Simplex Trading's TTPH Position: Q1 2019 in Review

Simplex Trading sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q1 2019, closing a stake of 671 shares — an estimated $17.1K sold.

Simplex Trading first reported a position in TTPH in Q4 2014 and held it in 11 quarters. The position peaked at $620K in Q3 2015. 78 funds tracked by Wall St. Rank hold TTPH as of Q1 2019.

  • Simplex Trading reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • Simplex Trading sold 671 Tetraphase Pharmaceuticals, Inc. shares in Q1 2019, an estimated $17.1K.
  • Simplex Trading first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2014 and held it in 11 quarters.
  • Simplex Trading's Tetraphase Pharmaceuticals, Inc. position peaked at $620K in Q3 2015.
  • 78 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q1 2019.

Based on Simplex Trading's 13F filing for Q1 2019, filed 18 Apr 2019.